NEW YORK (GenomeWeb) – Nearly a year after Agilent Technologies filed a lawsuit against Twist Bioscience alleging theft of intellectual property, Twist has filed a response denying the allegations and calling Agilent's suit an attempt "to stifle the legitimate and innovative work of a burgeoning start-up company and one of its top executives."